CDC: HPV Vaccine Rates Lag Behind Other Teen Vaccines

Report reveals vaccine coverage increased from 2009 to 2010 among adolescents aged 13-17 years

THURSDAY, Aug. 25 (HealthDay News) -- Vaccination coverage in adolescents appears to be increasing, however, the increase in human papillomavirus (HPV) coverage among adolescent females has been lagging, according to a report in the August 26 issue of the Centers for Disease Control and Prevention (CDC)'s Morbidity and Mortality Weekly Report.

The CDC evaluated 2010 National Immunization Survey-Teen (NIS-Teen) data and compared results with 2009 NIS-Teen estimates to update vaccination coverage estimates among adolescents aged 13 through 17 years.

The report revealed that coverage increased for combined tetanus, diphtheria and pertussis vaccines (Tdap) from 55.6 percent to 68.7 percent and meningococcal conjugate vaccine (MenACWY) from 53.6 percent to 62.7 percent. Among females, ≥ 1 dose of HPV increased from 44.3 percent to 48.7 percent and ≥ 3 doses of HPV increased from 26.7 percent to 32.0 percent. Vaccination coverage varied greatly among U.S. states. Massachusetts, Rhode Island, and Washington had coverage of >65 percent for ≥ 1 dose of Tdap, MenACWY, and HPV.

"Continued evaluation of vaccination-promoting initiatives, including state vaccination-financing policies, is needed to understand their impact on adolescent vaccination and to promote effective practices," the authors write.

Full Text

Copyright © 2011 HealthDay. All rights reserved.

Powered by